Necrotizing Enterocolitis
What's New
Last Posted: May 27, 2024
- SIGIRR gene variants in term newborns with congenital heart defects and necrotizing enterocolitis.
Ekaterina Konstantinovna Zaikova, et al. Annals of pediatric cardiology 2024 0 (5) 337-344 - Retracted: A Study on Fucosyltransferase 2 Gene Polymorphism and Secretion Status Related to Neonatal Necrotizing Enterocolitis.
Journal Of Healthcare Engineering, et al. Journal of healthcare engineering 2023 0 9873752 - Associations of VEGF Polymorphisms With Retinopathy of Prematurity.
Xiao Chun Ling, et al. Investigative ophthalmology & visual science 2023 0 (7) 11 - Hypoxia-Inducible Pathway Polymorphisms and Their Role in the Complications of Prematurity.
Ewa Strauss, et al. Genes 2023 0 (5) - The role of vitamin D receptor gene polymorphism in the development of necrotizing enterocolitis.
Barut Dogan, et al. Pediatric research 2023 0 - Transfusion-associated necrotizing enterocolitis in preterm infants: an updated meta-analysis of observational data.
Garg Parvesh, et al. Journal of perinatal medicine 2017 0 (6) 677-685 - Blood group AB increases risk for surgical necrotizing enterocolitis and focal intestinal perforation in preterm infants with very low birth weight.
Martynov I, et al. Scientific reports 2021 0 (1) 13777 - Genetic polymorphisms and risk for acute renal failure in preterm neonates.
Vásárhelyi Barna, et al. Pediatric nephrology (Berlin, Germany) 2005 0 (2) 132-5 - Randomized Trial on Echocardiography-Guided Ductus Arteriosus Treatment to Reduce Necrotizing Enterocolitis.
Bravo María Carmen, et al. Frontiers in pediatrics 2022 0 807712 - Loss-of-function SLC30A2 mutants are associated with gut dysbiosis and alterations in intestinal gene expression in preterm infants.
Kelleher Shannon L, et al. Gut microbes 2021 0 (1) 2014739
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: